Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors.

R. Romagnoli,P. Baraldi,T. Sarkar,M. D. Carrión,Carlota Lopez Cara,O. Cruz-López,D. Preti,M. Tabrizi,M. Tolomeo,S. Grimaudo,Antonella Di Cristina,Nicola Zonta,J. Balzarini,A. Brancale,H. Hsieh
DOI: https://doi.org/10.1021/jm7011547
IF: 8.039
2008-02-09
Journal of Medicinal Chemistry
Abstract:The 2-(3,4,5-trimethoxybenzoyl)-2-aminoindole nucleus was used as the fundamental structure for the synthesis of compounds modified with respect to positions C-4 to C-7 with different moieties (chloro, methyl, or methoxy). Additional structural variations concerned the indole nitrogen, which was alkylated with small alkyl groups such as methyl or ethyl. We have identified 1-methyl-2-(3,4,5-trimethoxybenzoyl)-3-amino-7-methoxyindole as a new highly potent antiproliferative agent that targets tubulin at the colchicine binding site and leads to apoptotic cell death.
What problem does this paper attempt to address?